From Zepbound to cancer care, insurance denials are up in 2026. Even with good insurance, consumers face steep bills for ...
Johnson & Johnson bets $1B on a Pennsylvania cell therapy plant as earnings momentum, pipeline deals, and MedTech approvals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results